Outpatient studies:
Our unit has been conducting outpatient research studies since 2006. We are currently accredited partner sites for the AID Clinical Trial Group (ACTG) and Tuberculosis Treatment Consortium (TBTC). Our site has conducted over 40 GCP standard high volume recruitment research studies in this period and our current and past portfolio includes amongst others:
• New TB treatment combination studies
• TB Treatment shortening studies
• Serial Sputum Conversion Studies
• Modified Early Bactericidal Activity continuation studies
• New TB Vaccine Studies
• COVID-19 Vaccine studies
• First in Human COVID-19 Vaccine studies
• MDR-TB treatment shortening studies
• MDR-TB household contact treatment studies
• HIV and TB new treatment combination studies
• TB and HIV intensive pK studies